Miriam Hospital recruiting for men's health research study
Study to test effectiveness of new drug for premature ejaculation
–The Miriam Hospital is recruiting local participants for a new study evaluating the effectiveness of an investigational drug being developed for the treatment of lifelong premature ejaculation (PE).
“Premature ejaculation (PE) is a condition that causes men to ejaculate rapidly before or during sexual intercourse,” said Martin Miner, M.D., co-director of The Men's Health Center at The Miriam Hospital. “This latest study may help improve sexual experiences for both men and their partners.”
The study will involve a minimum of six office visits over three and a half months at The Men's Health Center at The Miriam Hospital. It will include a four-week assessment period during which participants will be asked to have intercourse, record related information in an electronic diary and answer a few simple questions. If screening period results qualify the participant, and there is interest in continuing, participants will then take a study drug or placebo over the course of the following eight weeks. There is also a two-week follow-up period during which no treatment is administered.
Study participants may be eligible if they:
• Are a male between the ages of 18 to 60 years old.
• Have had lifelong premature ejaculation.
• Are in a monogamous heterosexual relationship.
• Are not planning pregnancy with their partner.
• Are willing to stop present treatment for premature ejaculation during study.
Participants will be compensated for study visits.
A common and treatable sexual complaint, PE affects as many as one out of three men at some time. Physical and emotional factors can contribute to the condition. For more information on the study, or to find out if you qualify, please contact Gail at 401-793-4335, firstname.lastname@example.org
(release from Lifespan)